Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer (original) (raw)

• Morgan, D.O. Principles of Cdk regulation. Nature 374, 131–134 (1995).
  Article CAS Google Scholar
• Sherr, C.J. & Roberts, J.M. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512 (1999).
  Article CAS Google Scholar
• Hanahan, D. & Weinberg, R.A. The hallmarks of cancer. Cell 100, 57–70 (2000).
  Article CAS Google Scholar
• Sherr, C.J. Cancer cell cycles. Science 274, 1672–1677 (1996).
  Article CAS Google Scholar
• Hunter, T. & Pines, J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 79, 573–582 (1994).
  Article CAS Google Scholar
• Weinstat-Saslow, D. et al. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Med. 1, 1257–1260 (1995).
  Article CAS Google Scholar
• Porter, P.L. et al. Expression of cell-cycle regulators p27kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222–225 (1997).
  Article CAS Google Scholar
• Baldassarre, B. et al. Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells. J. Clin. Invest. 10, 865–874 (1999).
  Article Google Scholar
• Rocco, J.W. & Sidransky, D. p16(MTS-1/CDKN2/INK4a) in cancer progression. Exp. Cell Res. 264, 42–55 (2001).
  Article CAS Google Scholar
• Otsuki, T., Clark, H.M., Wellmann, A., Jaffe, E.S. & Raffeld, M. Involvement of CDKN2 p16INK4A/MTS1) and p15INK4B/MTS2 in human leukemias and lymphomas. Cancer Res. 55, 1436–1440 (1995).
  CAS PubMed Google Scholar
• Sgambato, A., Cittadini, A., Faraglia, B. & Weinstein, I.B. Multiple functions of p27Kip1 and its alterations in tumor cells: A review. J. Cell Physiol. 183, 18–27 (2000).
  Article CAS Google Scholar
• Fero, M.L., Randel, E., Gurley, K.E., Roberts, J.M. & Kemp, C.J. The murine gene p27Kip1 is haplo-insufficient for tumor suppression. Nature 396, 177–180 (1998).
  Article CAS Google Scholar
• Catzavelos, C. et al. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer. Nature Med. 3, 227–230 (1997).
  Article CAS Google Scholar
• Lloyd, R.V., Jin, L., Qian, X. & Kulig, E. Aberrant p27Kip1 expression in endocrine and other tumors. Am. J. Pathol. 150, 401–407 (1997).
  CAS PubMed PubMed Central Google Scholar
• Loda, M. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27Kip1 in aggressive colorectal carcinomas. Nature Med. 3, 231–234 (1997).
  Article CAS Google Scholar
• Ciaparrone, M. et al. Localization and expression of p27Kip1 in multistage colorectal carcinogenesis. Cancer Res. 58, 114–122 (1998).
  CAS PubMed Google Scholar
• Singh, S. et al. Loss or altered subcellular localization of p27Kip1 in Barrett's associated adenocarcinoma. Cancer Res. 58, 1730–1735 (1998).
  CAS PubMed Google Scholar
• Jiang, Y., Zhao, R.C. & Verfaillie, C.M. Abnormal integrin-mediated regulation of chronic myelogenous leukemia CD34+ cell proliferation: BCR/ABL upregulates the cyclin-dependent kinase inhibitor, p27Kip1, which is relocated to the cell cytoplasm and incapable of regulating cdk2 activity. Proc. Natl. Acad. Sci. USA 97, 10538–10543 (2000).
  Article CAS Google Scholar
• Soucek, T., Yeung, R.S. & Hengstschlager, M. Inactivation of the cyclin-dependent kinase inhibitor p27Kip1 upon loss of the tuberous sclerosis complex gene-2. Proc. Natl. Acad. Sci. USA 95, 15653–15658 (1998).
  Article CAS Google Scholar
• Orend, G., Hunter, T. & Ruoslahti, E. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21 and p27 in anchorage-independent cells. Oncogene 16, 2575–2583 (1998).
  Article CAS Google Scholar
• Yaroslavskiy, B., Watkins, S., Donnenberg, A.D., Patton, T.J. & Steinman, R.A. Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells. Blood 93, 2907–2917 (1999).
  CAS PubMed Google Scholar
• Tomoda, K., Kubota, Y. & Kato, J. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398, 160–165 (1999).
  Article CAS Google Scholar
• Testa, J.R. & Bellacosa, A. AKT plays a central role in tumorigenesis. Proc. Natl. Acad. Sci. USA 98, 10983–10985 (2001).
  Article CAS Google Scholar
• Datta, S.R., Brunet, A. & Greenberg, M.E. Cellular survival: A play in three Akts. Genes Dev. 13, 2905–2927 (1999).
  Article CAS Google Scholar
• Datta, S.R. et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 91, 231–241 (1997).
  Article CAS Google Scholar
• Cardone, M.H. et al. Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318–1321 (1998).
  Article CAS Google Scholar
• Brunet, A. et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96, 857–868 (1999).
  Article CAS Google Scholar
• Kops, G.J. et al. Direct control of the forkhead transcription factor AFX by protein kinase B. Nature 398, 630–634 (1999).
  Article CAS Google Scholar
• Zhou, B.P. et al. (2001) Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nature Cell Biol. 3, 245–252 (2001).
  Article CAS Google Scholar
• Coffer, P.J., Jin, J. & Woodgett, J.R. Protein kinase B (c-Akt): A multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem. J. 335, 1–12 (1998).
  Article CAS Google Scholar
• Di Cristofano, A. & Pandolfi, P.P. The multiple roles of PTEN in tumor suppression. Cell 100, 387–390 (2000).
  Article CAS Google Scholar
• Lobenhofer, E.K., Huper, G., Iglehart, J.D. & Marks, J.R. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis. Cell Growth Differ. 11, 99–110 (2000).
  CAS PubMed Google Scholar
• Tsai, E.M, Wang, S.C., Lee, J.N. & Hung, MC . Akt Activation by estrogen in estrogen receptor-negative breast cancer cells. Cancer Res. 61, 8390–8392 (2001).
  CAS PubMed Google Scholar
• Lenferink, A.E., Busse, D., Flanagan, W.M., Yakes, F.M. & Arteaga, C.L. ErbB2/neu kinase modulates cellular p27Kip1 and cyclin D1 through multiple signaling pathways. Cancer Res. 61, 6583–6591 (2001).
  CAS PubMed Google Scholar
• Yang, H.Y., Shao, R., Hung, M.C. & Lee, M.H. p27Kip1 inhibits HER2/neu-mediated cell growth and tumorigenesis. Oncogene 20, 3695–3702 (2001).
  Article CAS Google Scholar
• Downward, J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr. Opin. Cell. Biol. 10, 262–267 (1998).
  Article CAS Google Scholar
• Sun, M. et al. AKT1/PKBα kinase is frequently elevated in human cancers and its constitutive activation is required for oncogenic transformation in NIH3T3 cells. Am. J. Pathol. 159, 431–437 (2001).
  Article CAS Google Scholar
• Diehl, J.A., Cheng, M., Roussel, M.F. & Sherr, C.J. Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499–3511 (1998).
  Article CAS Google Scholar
• Alt, J.R., Cleveland, J.L., Hannink, M. & Diehl, J.A. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev. 14, 3102–3114 (2000).
  Article CAS Google Scholar
• Liu, X. et al. Disruption of TGF-β growth inhibition by oncogenic ras is linked to p27Kip1 mislocalization. Oncogene 19, 5926–5935 (2000).
  Article CAS Google Scholar
• Bellacosa, A. et al. Akt activation by growth factors is a multiple-step process: The role of the PH domain. Oncogene 17, 313–325 (1998).
  Article CAS Google Scholar
• Baldassarre, G. et al. Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation. Oncogene 18, 6241–6251 (1999).
  Article CAS Google Scholar
• Bruni, P. et al. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: Evidence that PTEN-growth suppressing activity in thyroid cancer cells is mediated by p27kip1. Oncogene 19, 3146–3155 (2000).
  Article CAS Google Scholar
• Polyak, K., Lee, M., Koff, A., Roberts, J.M. & Massaguè, J. Cloning of p27Kip1 a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78, 59–66 (1994).
  Article CAS Google Scholar